Top Back to top

Guidelines on CMV management and vaccinations published in Lancet Infectious Diseases


The EBMT Infectious Diseases Working Party (IDWP) announces the publication in the Lancet Infectious Diseases journal of the paper entitled: “Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7)” prepared by Per Ljungman, Rafael de la Camara, Christine Robin, Roberto Crocchiolo, Hermann Einsele, Joshua A Hill, Petr Hubacek, David Navarro, Catherine Cordonnier, and Katherine N Ward, on behalf of the European Conference on Infections in Leukaemia group.

Cytomegalovirus is one of the most problematic infections occurring after allogeneic haematopoietic stem cell transplantation. Expert recommendations produced by the 2017 ECIL 7 cover diagnosis, preventive strategies such as prophylaxis and pre-emptive therapy, and management of cytomegalovirus disease.

The European Conference on Infections in Leukaemia (ECIL), established in 2005, is a joint venture of the IDWP, the Infectious Diseases Group of the European Organization for Research and Treatment of Cancer, the Immunocompromised Host Society, and the European Leukaemia Net. Its objective is to develop evidence-based guidelines for the management of infection in haematology and haemopoietic stem-cell transplantation patients.

A few month ago, two papers on vaccinations in patients after HSCT and in haematological patients after non-HSCT therapy were also published in Lancet Infectious Diseases, on behalf of ECIL, with Dr Malgorzata Mikulska and Dr Catherine Cordonnier being the first authors.